本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

136.39
-4.9800-3.52%
成交量:32.41万
成交额:4,457.34万
市值:139.12亿
市盈率:19.99
高:139.60
开:139.60
低:136.00
收:141.37
52周最高:186.12
52周最低:122.14
股本:1.02亿
流通股本:9,999.56万
量比:1.66
换手率:0.32%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
净资产收益率:22.09%
总资产收益率:11.70%
市净率:3.77
市盈率(LYR):29.21

数据加载中...

2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities